文章詳目資料

Journal of Medical Sciences MEDLINEScopus

  • 加入收藏
  • 下載文章
篇名 A Case of Refractory T‑cell Lymphoblastic Lymphoma Coexisting with ZMYM2‑Fibroblastic Growth Factor Receptor‑1 Fusion‑Related Myeloproliferative Disease and Review of Literatures
卷期 42:1
作者 Tsung‑Ying YuTzu‑Chuan HuangYi‑Ying Wu
頁次 050-052
關鍵字 T‑cell lymphoblastic lymphomamyeloproliferative diseaseZMYM2‑fibroblastic growth factor receptor‑1 fusion geneallogeneic hematopoietic stem cell transplantationMEDLINEScopus
出刊日期 202202
DOI 10.4103/jmedsci.jmedsci_230_21

中文摘要

英文摘要

T‑cell LBL (T‑LBL) is a rare lymphoma subtype in adults, and it usually has a dismal prognosis compared to other subtypes of non‑Hodgkin lymphoma. Here, we present a unique case of T‑LBL with myeloproliferative disease. A distinct fusion gene of ZMYM2‑FGFR1 translocation was detected through next‑generation sequencing, and this might be correlated with the translocation of chromosomes 8 and 13 (t[8;13]). Her disease condition seemed to be refractory to multiple lines of chemotherapy. Her lymphoma finally achieved a complete remission after a matched related allogeneic hematopoietic stem cell transplantation.

本卷期文章目次

相關文獻